Fifty years ago today, the first and only blue-ribbon committee on marijuana policy formally recommended that Congress repeal federal penalties criminalizing the personal possession of marijuana.
“Congressman Young was a passionate supporter of ending America’s failed marijuana prohibition and implementing a legalization policy based on personal freedom and individual liberty.”
“Seventy percent of voters approved this right at the ballot box and it is reassuring to see that a majority of lawmakers, and the Governor, ultimately decided to respect the voters’ decision.”
This week’s update highlights important legislative advancements in Illinois, Utah, South Dakota, and Kentucky, focuses on upcoming hearings, and provides updates on several other important bills moving forward across the country.
With a vote of 59 to 34, members of the Kentucky House of Representatives have advanced House Bill 136 to the Senate for further consideration. The bill provides for the production and distribution of a limited variety of medical cannabis products to qualified patients, including those with PTSD, cancer, chronic pain, epilepsy or any other intractable seizure disorder; multiple sclerosis, muscle spasms, or spasticity; and nausea or vomiting.
“The attitudes and priorities of federal prosecutors have shifted in the era of state-level marijuana legalization.”
A robust, above-ground retail marijuana market is necessary in order to disrupt the unregulated marketplace and to assure that consumers have adequate access to lab-tested, high quality products at competitive prices.
Last week, Delaware’s House of Representatives missed another chance to legalize cannabis for adults 21 and older. HB 305 needed to clear a legislative hurdle requiring a three–fifths super majority, or 25 votes. The final tally on March 10th was 23-14-4.